Table 3.
Linear regression between changes in FLI, BAAT and WC with specific LPC concerning both intervention treatments taking into account sex, age and dietary group
| (n = 33) | β | p | P model | R2 |
|---|---|---|---|---|
| Δ FLI | ||||
| Δ LPC14:0 | 5.58 | 0.078 | 0.066 | 0.167 |
| Δ LPC15:0 | 7.19 | 0.308 | 0.037 | 0.209 |
| Δ LPC16:1 | 3.49 | 0.096 | 0.028 | 0.221 |
| Δ LPC18:4 | 12.27 | 0.111 | 0.033 | 0.210 |
| Δ LPC20:4 | 0.28 | 0.753 | 0.047 | 0.185 |
| Δ BAAT | ||||
| Δ LPC14:0 | 0.45 | 0.010 | 0.016 | 0.274 |
| Δ LPC15:0 | 0.50 | 0.154 | 0.327 | 0.029 |
| Δ LPC16:1 | 0.12 | 0.209 | 0.509 | 0.017 |
| Δ LPC18:4 | 0.47 | 0.205 | 0.487 | 0.013 |
| Δ LPC20:4 | 0.00 | 0.902 | 0.789 | 0.032 |
| Δ WC | ||||
| Δ LPC14:0 | −0.00 | 0.957 | 0.441 | 0.004 |
| Δ LPC15:0 | 4.93 | 0.162 | 0.044 | 0.196 |
| Δ LPC16:1 | 0.85 | 0.133 | 0.332 | 0.025 |
| Δ LPC18:4 | 3.13 | 0.165 | 0.336 | 0.024 |
| Δ LPC20:4 | 0.13 | 0.031 | 0.112 | 0.121 |
Models were adjusted for sex, age and dietary group. FLI Fatty Liver Index; BAAT score, WC Waist Circumference, LPC14:0 Lysophosphatidylcholine 14:0, LPC15:0 Lysophosphatidylcholine 15:0, LPC16:1 Lysophosphatidylcholine 16:1, LPC18:4 Lysophosphatidylcholine 18:4, LPC20:4 Lysophosphatidylcholine 20:4